4 results  1 of 1 

1 Role of Roflumilast Combined with ESHAP Chemotherapy in Relapsed/Refractory Patients with Diffuse Large B-Cell Lymphoma
Do Young Kim, Jehyun Nam, Joo-seop Chung, Sang-Woo Kim, Ho-Jin Shin
Cancer Res Treat.2022;54(1):301-313.   Published online 2021 April 27     DOI: http://dx.doi.org/10.4143/crt.2020.1371
      
2 Incidence of Adverse Effects and Discontinuation Rate between Patients Receiving 250 Micrograms and 500 Micrograms of Roflumilast: A Comparative Study
Hyonsoo Joo, Deokjae Han, Jae Ha Lee, Chin Kook Rhee
Tuberc Respir Dis.2018;81(4):299-304.   Published online 2018 June 19     DOI: http://dx.doi.org/10.4046/trd.2018.0015
      
3 The Phosphodiesterase 4 Inhibitor Roflumilast Protects against Cigarette Smoke Extract-Induced Mitophagy-Dependent Cell Death in Epithelial Cells
Sun Young Kyung, Yu Jin Kim, Eun Suk Son, Sung Hwan Jeong, Jeong-Woong Park
Tuberc Respir Dis.2018;81(2):138-147.   Published online 2018 March 13     DOI: http://dx.doi.org/10.4046/trd.2017.0115
      
4 Efficacy and Safety of Roflumilast in Korean Patients with COPD
Jae Seung Lee, Yoon Ki Hong, Tae Sun Park, Sei Won Lee, Yeon-Mok Oh, Sang-Do Lee
Yonsei Med J.2016;57(4):928-935.   Published online 2016 May 10     DOI: http://dx.doi.org/10.3349/ymj.2016.57.4.928
      

 1 of 1